GIRI v. NATIONAL BOARD OF MEDICAL EXAMINERS
Filing
28
MEMORANDUM OPINION re 27 Order Granting 23 Defendant's Motion to Dismiss. See full Memorandum Opinion for details. Signed by Judge Christopher R. Cooper on 1/27/2025. (lccrc1)
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA
LATIKA GIRI, et al.,
Plaintiffs,
v.
Case No. 24-cv-410 (CRC)
THE NATIONAL BOARD OF MEDICAL
EXAMINERS,
Defendant.
MEMORANDUM OPINION
This is the Court’s second occasion to consider Dr. Latika Giri’s allegations that the
National Board of Medical Examiners (“NBME” or “the Board”) unlawfully discriminated
against test-takers of Nepali ethnicity and national origin by invalidating their medical licensing
examination results. Giri previously filed an emergency motion for a preliminary injunction to
reinstate her scores. In its last opinion, the Court concluded that such extraordinary relief was
not warranted because the record demonstrated that NBME took action against Giri and other
Nepali examinees due to evidence of widespread cheating, not discriminatory animus.
Following the Court’s ruling, Giri and an additional plaintiff, Dr. Sweccha Shrestha, filed
an amended complaint. NBME has moved to dismiss. Unfortunately for Plaintiffs, this second
bite at the apple is no more successful than the first. Giri and Shrestha waived their claims
against NBME by signing release forms prior to filing their amended complaint, so the Court
must dismiss the case for lack of subject matter jurisdiction. And even if Plaintiffs had not
surrendered their claims, the Court still would dismiss the amended complaint because it fails to
state valid discrimination claims.
I.
Background
The Court described much of the legal and factual background of this case in its prior
opinion, so it provides only a summary of the relevant details here. Giri v. Nat’l Bd. of Med.
Exam’rs (Giri I), 718 F. Supp. 3d 30 (D.D.C. 2024). The Court takes the following facts from
Plaintiffs’ amended complaint as true. See Jerome Stevens Pharms., Inc. v. FDA, 402 F.3d
1249, 1253–54 (D.C. Cir. 2005). 1
A. The USMLE and the Match Program
The United States Medical Licensing Exam (“USMLE”) is a standardized test
administered by NBME and the Federation of State Medical Boards every year to aspiring
doctors who wish to practice medicine in the United States. Giri I, 718 F. Supp. 3d at 34. It
consists of three steps: Step One is a written exam that measures students’ grasp of various
scientific concepts and their application to the practice of medicine. Am. Compl. ¶ 10. Step
Two is another written exam assessing test-takers’ ability to apply “medical knowledge, skills,
and understanding of clinical science to the provision of patient care under supervision.” Id.
¶ 11. And Step Three, which includes a written exam and clinical simulation, measures whether
examinees “have the knowledge and skills of physicians assuming independent responsibility for
patient care.” Id. ¶ 12. Graduates of both U.S. and foreign medical schools may sit for the
USMLE.
Once graduates of foreign medical schools have completed the USMLE, they are
certified by the Educational Commission for Foreign Medical Graduates (“ECFMG”) as eligible
to apply for residency programs through the National Resident Matching Program (“Match
program”). Id. ¶ 15. All applicants must pass the first two steps to participate in the Match
1
Some facts are also drawn from the exhibits to NBME’s motion to dismiss.
2
program. Id. ¶ 14. Step Three is optional, but most residency programs require completion of
that step as well. Id.
The Match cycle begins in September, when applicants may register for the program. Id.
¶ 16. Then, each February, medical school graduates rank their preferred residency programs in
order, and residency programs likewise rank applicants. Id. Once the rankings are complete, the
Match program uses an algorithm to place applicants with residency programs. Id.; Giri I, 718 F.
Supp. 3d at 34. The results are unveiled on Match Day in mid-March. Am. Compl. ¶ 16.
Graduates’ USMLE scores are an important consideration in residency programs’ matching
decisions. Id. ¶ 17.
The USMLE is administered multiple times during the year, and some questions are
recycled from one test administration to the next. Id. ¶ 18. That repetition entails some risk that
examinees may memorize or copy exam questions and disseminate them to future test-takers—a
risk NBME has foreseen. Id. ¶ 19–20. When validity of any particular exam result is called into
question, NBME delays release of the score if it has not yet been released and delays further
distribution of the score if it has. Id. ¶ 20. NBME then provides test-takers with an opportunity
to respond to the suspicion that their scores are invalid. Id. The score is cancelled only if the
examinee fails to timely respond to this inquiry or provides an inadequate explanation. Id.
B. Investigation into Exams Associated with Nepal
By early 2023, the Board had received several anonymous tips claiming that groups of
examinees from India, Nepal, Pakistan, and Jordan had distributed prior exam questions in
advance of testing. Id. ¶ 21. Tipsters alleged that applicants were relying on question banks
containing live USMLE material to attain high scores. Id. ¶ 22. One tip stated that in India and
Nepal, test-takers were “purchasing last six months question papers.” Id. ¶ 22; id., Ex. A (“First
3
Ward Decl.”) ¶ 6. Another indicated that some test-takers were sharing exam information at
study centers located in Kathmandu and in an online group on the “Telegram” app. Am. Compl.
¶ 24. The Board also discovered posts on social media and online chat rooms “suggesting that
groups of individuals in Nepal were collecting and sharing large amounts of secure exam
material in private groups.” First Ward Decl. ¶ 7.
In response to the Telegram tip, NBME dispatched an undercover investigator to
infiltrate the Telegram group, in which past exam questions (“PQs”) were reportedly being
shared. Am. Compl. ¶ 25; First Ward Decl. ¶ 9. To join the group, the investigator was required
to furnish a USMLE testing permit and documents showing some nexus to Nepal. First Ward
Decl. ¶ 10.
Accessing the Telegram group confirmed the reports: Individuals were sharing “re-calls”
from examinees of prior USMLE questions that were still in active use. Id. ¶ 12. Participants
boasted that many of the questions they encountered on their Step One exams were “PQs” shared
within the group. Id. ¶ 13. One poster encountered “around 75% pqs,” with most of their friends
recognizing “around 90-95%” of questions. Id. Other posters echoed the sentiment, touting PQs
as their “saviour.” Id. (capitalization omitted).
Members of the Telegram group also worried aloud about raising suspicions of cheating.
One expressed unease about the rate at which test-takers were racing through their exams and
answering questions they had already encountered. Id. ¶ 14. “No one is with that type of super
power to finish that exam this much early,” the poster observed. Id. Another warned
participants of the “consequences of talking about pq” when leaving the test center. Id.
In early 2023, the program responded to the anonymous tips and other information by
asking NBME’s Psychometrics and Data Analysis (“PADA”) department to “analyze examinee
4
performance data for test centers in Jordan, Nepal, and Pakistan.” Am. Compl., Ex. B (“Jurich
Decl.”) ¶ 6. The results from Nepal were the most extreme. Id. ¶ 7. The country’s sole test
center produced the highest average scores in the world on the 2021 and 2022 Step One and
2022 Step Two exams. Id. Compounding NBME’s suspicions, examinees who tested at the
Nepal center in 2022 were among the fastest 5% for the Step One exam and fastest 10% for Step
Two, out of all test-takers worldwide. Id. The number of examinees at the Nepal test center had
also more than doubled in the span of three years. Id.
Around April 2023, PADA ran an “agreement analysis” focused on test centers in Jordan,
Nepal, Pakistan, and India designed to identify sets of exams that contained a “statistically
improbable number of the same incorrect response options to the same questions,” which could
be indicative of prior, shared access to secure exam materials. Jurich Decl. ¶¶ 8, 9; Am. Compl.
¶ 28. The results—which focused on Step One and Step Two exam data from 2021 and 2022—
showed that “the vast majority of examinees with a statistically significant number of matching
incorrect answers tested at the Nepal test center.” Jurich Decl. ¶ 9. A re-run of that analysis in
July 2023 focused on “examinees who tested at the Nepal test center and/or were citizens of
Nepal[.]” Id. ¶ 11. The new analysis yielded similar results, as did an inquiry into Step Three
exams completed by individuals who attended medical school in Nepal or self-reported as a
citizen of Nepal. Id. ¶¶ 12–13.
PADA later developed criteria for identifying passing exam results of dubious validity,
including incorrect-response correlation, median response times, and substantial differences in
performance on different steps of the exam, among other factors. Id. ¶¶ 15, 17. After applying
this analysis to test-score data from the Nepal test center, self-reported citizens of Nepal, and
graduates of Nepali medical schools, NBME identified 832 examinees (or roughly forty percent
5
of the sample group) from 2021 through 2023 with at least one dubious exam result. Id. ¶¶ 18–
19. Departing from its usual procedures, the Board immediately invalidated the suspect scores
and instructed the affected examinees to destroy their ECFMG certificates. Am. Compl. ¶ 46,
48; id., Ex. C (“Mechaber Decl.”) ¶ 20.
C. Dr. Giri’s Case
Dr. Giri is a citizen and current resident of Nepal who graduated from the Kathmandu
University School of Medical Sciences in 2022. Am Compl. ¶ 3. NBME invalidated her Step
One, Two, and Three scores because all three exams displayed “[e]xtremely improbable answer
similarity with other examinees testing on the same form at similar times[,]” and “[a]bnormal
question response times[.]” Jurich Decl., Attach. C (“Email to Giri”). In a January 31, 2024
email notifying Giri that her scores had been invalidated, NMBE indicated that the likelihood of
observing Giri’s data results “during normal testing conditions” was roughly 1 in 100 million.
Id.
The Board offered Giri three alternative forms of recourse: she could retake each step of
the examination, request reconsideration of NBME’s decision to invalidate her score, or take no
action, in which case she would be suspended from retaking the USMLE for three years. Email
to Giri. She was required to report her choice within fifteen calendar days. Id. at 2.
That same day, the Board released a statement on the USMLE website explaining that
that it had invalidated certain examinees’ test scores, stating, in part:
The USMLE program regularly monitors and analyzes examinees’
test performances for unusual score patterns or variations, and other
information that could raise questions about the validity of an
examinee’s results. As part of an ongoing investigation, the
USMLE program has identified a pattern of anomalous exam
performance associated with Nepal, which challenges the validity of
test results for a group of examinees. Highly irregular patterns can
be indicative of prior unauthorized access to secure exam content.
6
Examinees with results in question are being notified by the USMLE
Secretariat’s Office that their previous Step scores have been
invalidated and that they will be required to take a validation
exam(s). The USMLE program is working to notify examinees who
need to schedule validation exam(s) and to support score users and
other stakeholders impacted by the validation exam requirements.
Mechaber Decl., Attach. C (“USLME Program Statement”).
Giri filed a putative class action on February 12, 2024 on behalf of the 832 Nepalassociated examinees whose USMLE scores were invalidated, alleging that NBME had
discriminated against her and other putative class members on the basis of their Nepali national
origin and ethnicity, in violation of Title VII and 42 U.S.C. § 1981. See Am. Compl. ¶¶ 57, 60,
73–81. She simultaneously filed an emergency Motion for a Preliminary Injunction ordering
NBME to reinstate class members’ test scores in time for the February 28 rank-order list
deadline. See Mot. Prelim. Inj. NBME extended the deadline for putative class members to
elect which of the three options they intended to pursue until the Court ruled on the preliminaryinjunction motion. See Joint Stipulation, ECF No. 9, ¶ 1; Order Adopting Stipulation, ECF No.
10, ¶ 1.
Eleven days later, following expedited briefing and a hearing, the Court denied Giri’s
motion for a preliminary injunction, concluding that she was unlikely to succeed on her claims
because the record “demonstrate[d] that NBME took action against the putative class because of
credible reports of cheating, not discriminatory animus against Nepalis.” Giri I, 718 F. Supp. 3d
at 33. The same day, Giri responded to NBME’s letter. Mot. to Dismiss, Attach. 1 (“Second
Ward Decl.”) ¶ 11; id., Ex. C (“Giri Response Form”) at 1. She selected the second option
provided by NBME, requesting reconsideration of the USMLE program’s decision to invalidate
her scores. Second Ward Decl. ¶ 13.
7
In submitting her response form, Giri agreed to the following waiver:
I acknowledge that the USMLE program is giving me the
opportunity to request reconsideration of the decision to invalidate
one or more of my passing level Step exam outcomes, to appeal any
adverse decision that is made if I seek such reconsideration, and to
retake the applicable Step exam(s) at no cost if I elect to do so and
am otherwise eligible. In exchange, I release the USMLE program
and its owners from all claims that I might have that relate in any
way to the invalidation of my Step exam outcome(s).
Giri Response Form at 1; see Am. Compl. ¶ 49.
D. Dr. Shrestha’s Case
After the Court denied Giri’s preliminary-injunction motion, she filed an amended
complaint in April 2024. The amended complaint adds Plaintiff Dr. Swechha Shrestha, a
medical resident of Nepali citizenship and ancestry who lives in Nevada. Am. Compl. ¶ 4. In
January 2024, NMBE notified Shrestha by email that it had invalidated her Step Three exam
score due to concerns about its validity. Second Ward Decl. ¶ 14; id., Ex. D (“Email to
Shrestha”). Shrestha, like Giri, elected to request reconsideration of the program’s decision to
invalidate her score. Second Ward Decl. ¶ 18. In doing so, she likewise agreed to the waiver
quoted above. Id. ¶ 17; Ex. E (“Shrestha Response Form”) at 1. While the record is short on
details, the amended complaint identifies Dr. Shrestha as a “medical resident.” Am. Compl. ¶ 4.
Presumably, then, she previously participated in the Match and was placed in a residency
program that did not require a passing score on Step Three of the USMLE. In any case, the
amended complaint explains that while she was “not required to leave the country” following the
invalidation of her score, she “must retake Step 3 of the exam in order to continue her residency
program[.]” Id. ¶ 55. In the meantime, she “maintains a demanding schedule.” Id.
8
II.
Legal Standards
NBME moves to dismiss Plaintiffs’ complaint under Federal Rules of Civil Procedure
12(b)(1) and 12(b)(6).
When the Court’s subject-matter jurisdiction is challenged under Rule 12(b)(1), “the
plaintiff[] bear[s] the burden of proving by a preponderance of the evidence that the Court has
subject matter jurisdiction[.]” Biton v. Palestinian Interim Self–Gov’t Auth., 310 F. Supp. 2d
172, 176 (D.D.C. 2004). The court construes the allegations contained in the complaint in the
plaintiff's favor. M.J. v. D.C., 401 F. Supp. 3d 1, 7 (D.D.C. 2019). When assessing subjectmatter jurisdiction, unlike a motion to dismiss for failure to state a claim, a court may consider
material outside of the complaint, Herbert v. Nat’l Acad. of Scis., 974 F.2d 192, 197 (D.C. Cir.
1992), but factual discrepancies are resolved in favor of the plaintiff, Crane v. N.Y. Zoological
Soc’y, 894 F.2d 454, 456 (D.C. Cir. 1990).
“To survive a motion to dismiss [under Rule 12(b)(6)], a complaint must contain
sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.’”
Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544,
570 (2007)). A claim is plausible “when the plaintiff pleads factual content that allows the court
to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Id. A
court “must treat the complaint’s factual allegations as true and must grant plaintiff the benefit of
all inferences that can be derived from the facts alleged.” Sparrow v. United Air Lines, Inc., 216
F.3d 1111, 1113 (D.C. Cir. 2000) (cleaned up). Although a complaint need not provide “detailed
factual allegations” to withstand a 12(b)(6) motion, it must offer “more than labels and
conclusions.” Twombly, 550 U.S. at 555.
9
III. Analysis
Giri and Shrestha signed release forms waiving the claims that are the subject of this suit.
Accordingly, the Court will dismiss their claims for lack of subject-matter jurisdiction. Even if
the Court were to reach the merits of their claims, Plaintiffs fail to state discrimination claims
under Title VII or 42 U.S.C. § 1981. The Court would therefore dismiss their claims under Rule
12(b)(6) in any case.
A. Prior Release of Claims
NBME contends that Giri’s and Shrestha’s claims are barred by the release forms they
signed when requesting reconsideration of NBME’s decision to invalidate their scores. As an
initial matter, the Court notes some disagreement among courts in this Circuit about whether
such waivers are appropriately resolved under Rule 12(b)(1) or 12(b)(6). Compare Blount v.
Johnson, No. 15-769 (RMC), 2016 WL 5313558, at *6–8 (D.D.C. Sept. 22, 2016) (dismissing
claims barred by plaintiff’s settlement agreement under Rule 12(b)(6)), aff’d sub nom. Blount v.
Duke, No. 16-5354, 2017 WL 4217463, at *1 (D.C. Cir. Aug. 23, 2017), with Devorah v. Royal
Bank of Canada, 115 F. Supp. 3d 35, 38–39 (D.D.C. 2015) (Cooper, J.) (dismissing claims
barred by plaintiff’s settlement agreement under Rule 12(b)(1)). NBME does not take a position
in its motion on whether Rule 12(b)(1) or 12(b)(6) is the appropriate vehicle for dismissal,
relying in the alternative on both rules. See Mot. to Dismiss at 13.
The Court concludes, as it has before, that dismissing waived claims implicates its
subject matter jurisdiction and is appropriately accomplished under Rule 12(b)(1). The Court
confronted this question in Devorah v. Royal Bank of Canada, where the plaintiff had executed
an agreement releasing the Royal Bank of Canada and its affiliates from claims related to the
handling of her investment accounts. 115 F. Supp. 3d at 37. Although the defendants had
10
“styled their motion to dismiss as one for failure to state a claim,” the Court explained that a
release contained in “a valid settlement agreement in fact removes the Court’s jurisdiction to
hear a plaintiff’s complaint.” Id. at 38 n.1 (citing Allen v. Nicholson, 573 F. Supp. 2d 35, 38
(D.D.C. 2008)).
Several other cases from this district hold the same. See, e.g., Lindell v. Landis Corp.
401(k) Plan, 640 F. Supp. 2d 11, 14–15 (D.D.C. 2009); Stanley v. George Washington Univ.,
394 F. Supp. 3d 97, 106 (D.D.C. 2019), aff’d, 801 F. App’x 792 (D.C. Cir. 2020); Jacobs v. NotFor-Profit Hosp. Corp., 285 F. Supp. 3d 316, 318 (D.D.C. 2018). 2 Those cases reflect the
understanding that “[f]ederal courts lack jurisdiction over a matter that has been settled because,
after settlement, the matter does not present an actual controversy suitable for judicial
resolution.” Jacobs, 285 F. Supp. 3d at 318. Thus, claims barred by a valid waiver are moot and
“[t]he Court lacks subject matter jurisdiction over [those] released claims.” Stanley, 394 F.
Supp. 3d at 106.
To be sure, Plaintiffs have not executed a settlement agreement with NBME. But the
effect of the release they signed is the same. So long as the release covers Plaintiffs’ claims and
is not invalid, it “effectively settle[s] the controversy” and renders Plaintiffs’ claims moot. See
Allen, 573 F. Supp. 2d at 38. And under Rule 12(b)(1), the Court may consider material outside
2
The Court acknowledges that the unpublished D.C. Circuit opinion affirming Stanley
states, without further reasoning, that “Stanley’s claims are therefore properly dismissed under
Federal Rule of Civil Procedure Rule 12(b)(6).” Stanley, 801 F. App’x at 793. But the opinion
does not mention the district court’s reliance on Rule 12(b)(1), much less grapple with the
distinction between the two rules, and therefore does not displace the cited district court cases
indicating that Rule 12(b)(1) is the appropriate vehicle for dismissal here.
11
of the complaint, including the Second Ward Declaration offered by NBME and the release
forms agreed to by Giri and Shrestha. See Herbert, 974 F.2d at 197. 3
Plaintiffs’ claims against NBME fall within the scope of the waivers they signed. Each
agreed to “release the USMLE program and its owners from all claims that I might have that
relate in any way to the invalidation of my Step exam outcome(s).” Giri Response Form at 1;
Shrestha Response Form at 1. Plaintiffs do not contend otherwise. See Opp’n at 32 (“Plaintiffs
acknowledge that the release, if enforceable, would bar their claims here.”). Instead, they argue
only that their releases are not enforceable because they resulted from “economic duress.” Id.
Unfortunately for Plaintiffs, the amended complaint comes nowhere close to plausibly alleging
economic duress.
First, as NBME correctly notes, even a plausible assertion of economic duress “merely
renders a contract voidable—as opposed to void[.]” Schmidt v. Shah, 696 F. Supp. 2d 44, 64
(D.D.C. 2010); Wright v. Foreign Serv. Grievance Bd., 503 F. Supp. 2d 163, 175 (D.D.C. 2007),
aff’d, No. 07-5328, 2008 WL 4068606 (D.C. Cir. Mar. 17, 2008). 4 Thus, “a plaintiff who
accepts the benefits of the contract entered into under economic duress cannot later seek to have
the contract rescinded.” Wright, 503 F. Supp. 2d at 175. Here, Giri and Shrestha have accepted
the benefits of signing their respective release forms. Both requested reconsideration of
3
Even if this motion is properly brought under Rule 12(b)(6), the Court nonetheless
could likely consider the waivers Plaintiffs executed because they are referenced in the amended
complaint. Am Compl. ¶ 49; see Langeman v. Garland, 88 F.4th 289, 292 (D.C. Cir. 2023)
(noting that under Rule 12(b)(6), a court may consider documents “attached to a motion to
dismiss if they are ‘referred to in the complaint,’ integral to the claim(s), and if their authenticity
is undisputed”).
4
The parties agree that the Court need not resolve whether the law of the District of
Columbia or Pennsylvania (where NBME is headquartered) applies to Plaintiffs’ economic
duress argument, because both jurisdictions adhere to the Restatement Second on this issue. See
Opp’n at 32 n.2; Reply at 2 n.2.
12
NBME’s decision to invalidate her score. Giri Response Form at 3; Shrestha Response Form at
3. And both presumably plan to retake the USMLE. See Am Compl. ¶ 55; Opp’n at 31. Given
that Plaintiffs have “sought to keep the benefits of” the releases they signed, they cannot
challenge those releases to litigate their waived claims. Shah, 696 F. Supp. 2d at 64.
In any event, Plaintiffs have not plausibly alleged that economic duress drove them to
sign their releases. The two elements of economic duress are “(1) an improper threat and (2) the
lack of a reasonable alternative.” Osborne v. Howard Univ. Physicians, Inc., 904 A.2d 335, 339
(D.C. 2006). Plaintiffs have alleged neither element. They contend that NBME acted
improperly when it “threatened to forbid Plaintiffs from sitting for NBME’s exam, which would
do nothing to further NBME’s business,” unless they signed the release forms. Opp’n at 33. But
the Court sees nothing improper in NBME’s decision to respond to highly credible evidence of
cheating by suspending access to the exam for the examinees in question unless they cooperated
with NBME’s process.
Plaintiffs also argue that NBME acted improperly by requesting waivers only from the
subset of test-takers whose scores were invalidated, a group that NBME allegedly
discriminatorily identified. Opp’n at 34. But the improper-threat analysis focuses on “any
intentional pressure or threats applied by the contracting party to enter into the agreement,” not
on the party’s underlying claims. See Jung v. Ass’n of Am. Med. Colls., 300 F. Supp. 2d 119,
151 (D.D.C. 2004). Here, then, the question is whether Plaintiffs were improperly pressured into
signing the waivers—a separate inquiry from whether their scores should have been invalidated
in the first place. Plaintiffs offer no facts suggesting such improper pressure.
Second, Plaintiffs fail to allege that they had no reasonable alternative to signing the
waivers. To the contrary, Giri had already begun this litigation and both Plaintiffs could have
13
continued to seek redress through legal means, rather than requesting that NBME reconsider
their score invalidations. “[A] legal remedy may represent a reasonable alternative to signing a
contract” unless the plaintiff alleges “facts establishing specific financial harm that make
litigation an unreasonable alternative.” Osborne, 904 A.2d at 340–41; see La France v.
Georgetown Univ. Hosp., No. 87-3400 (RCL), 1988 WL 135066, at *3 (D.D.C. Dec. 9, 1988)
(noting that a permanent employee has a reasonable alternative to agreeing to an employer’s
severance terms because he “can always sue for breach of the employment contract”). Plaintiffs
allege no facts that suggest they could not have pursued their aims by continuing their alreadystarted litigation. That is particularly so given that, as Plaintiffs acknowledge, they were able to
practice medicine outside the United States, see Opp’n at 34, and that even taking no action in
response to NBME’s letter would have resulted in only a three-year suspension from the
USMLE, not a permanent bar. Email to Giri; Email to Shrestha.
Plaintiffs liken the waiver to improper threats of termination by an employer, but the
cases they cite are distinguishable. See, e.g., Laemmar v. J. Walter Thompson Co., 435 F.2d
680, 682 (7th Cir. 1970). As the Court will next discuss, NBME is not Plaintiffs’ employer.
Moreover, Giri, at least, had not yet secured a residency position or salary at the time that her
score was invalidated. Additional delay in the process of obtaining licenses thus imposed less
economic pressure on her than losing one’s current job, especially since, as just noted, Giri was
free to practice medicine outside the United States. As for Shrestha, Plaintiffs acknowledge that
she was “not required to leave the country” following the invalidation of her score, so she could
14
have sought the redress through litigation discussed above with minimal disruption. Am. Compl.
¶ 55. 5
The Court therefore concludes that Plaintiffs have not plausibly alleged economic duress.
Compounding the Court’s holding are the following observations: Plaintiffs are sophisticated
professionals; at least one Plaintiff was represented by counsel at the time she signed the release;
and NBME provided Plaintiffs with a reasonable amount of time to consider whether to sign the
release forms—indeed, NBME extended that deadline until after the Court ruled on Giri’s
preliminary-injunction motion. See Joint Stipulation ¶ 1. Because the waivers are enforceable,
the Court will dismiss Plaintiffs’ claims for lack of subject matter jurisdiction.
B. Merits
Even if Plaintiffs’ claims were not barred by the waivers they signed, the Court would
dismiss all claims on the merits. Plaintiffs have not stated Title VII claims because NBME is not
their employer. And Plaintiffs have not stated Section 1981 claims because they have not
plausibly alleged discrimination on the basis of ethnicity, as distinct from national origin.
1. Title VII Claims
Plaintiffs’ Title VII claims fail because NBME does not qualify as an employer for
purposes of the statute. Plaintiffs acknowledge that they are not employed by NBME but argue
that it is nonetheless subject to Title VII liability under the interference theory set forth in Sibley
5
The Court also observes that Shrestha, a current medical resident, must have matched
with a program that does not require a passing score on Step Three of the USMLE. See Am.
Compl. ¶ 4. Shrestha now alleges that she “must retake Step 3 of the exam in order to continue
her residency program,” id. ¶ 55, but the Court wonders how this can be so. Plaintiffs allege that
Step Three is optional for some residency programs, but they do not allege that Step Three can
become mandatory after a resident has already matched without it. See id. ¶ 14. To the extent
Shrestha in fact wishes to take Step Three so she may transfer to a different residency program,
as the Court suspects, that further weakens any claim of economic duress.
15
Memorial Hospital v. Wilson, 488 F.2d 1338 (D.C. Cir. 1973). See Opp’n at 14–16. There, the
D.C. Circuit held that in some circumstances, Title VII covers entities “who are neither actual
nor potential direct employers of particular complainants, but who control access to such
employment and who deny such access by reference to invidious criteria.” Sibley, 488 F.2d at
1342.
Plaintiffs’ claims do not resemble those found to be cognizable in Sibley. That case
concerned a “registry and referral system” through which private nurses were matched with
patients at a hospital. Id. at 1339. Though the hospital did not employ the nurses, “the
relationship of the hospital to the employment by its patients of private duty nurses secured for
them by the hospital was very close.” George v. N.J. Bd. of Veterinary Med. Exam’rs., 794 F.2d
113, 114 (3d Cir. 1986). The D.C. Circuit thus concluded that the hospital could be held liable
under Title VII for the allegedly discriminatory practices it used to match nurses with patients.
Sibley, 488 F.2d at 1342. In contrast, here, as in other cases concerning the relationship between
licensees and their professional boards, “there [is] nothing even remotely resembling an
employer-employee relationship between the Board and the plaintiff[s].” George, 794 F.2d at
114.
Indeed, the weight of authority falls against Plaintiffs on this issue. Although licensing
boards can enjoy “complete control over access [to] the regulated professional job market,”
“such boards have been routinely held not to be employers.” Johnson v. Greater Se. Cmty.
Hosp. Corp., 903 F. Supp. 140, 156 (D.D.C. 1995) (emphasis in original) (collecting cases),
order vacated in part, No. 90-1992 (RCL), 1996 WL 377147 (D.D.C. June 24, 1996). NBME
does not issue medical licenses. Instead, “[m]edical licensing authorities across the country rely
upon the USMLE to help evaluate the qualifications of individuals seeking an initial license to
16
practice medicine and to determine their eligibility for medical licensure.” Mechaber Decl. ¶ 5.
NBME is thus even further removed from decisions relating to a medical resident’s ultimate
employment than licensing boards, and even less appropriately subject to Title VII liability. See
Mot. to Dismiss at 22–23. Reflecting that understanding, in a case very similar to this one, the
Central District of California rejected Title VII claims against NBME, reasoning that “NBME
only administers the licensing exam and reports the scores to residency programs, which does
not constitute ‘procuring employees.’” Kiprilov v. Nat’l Bd. of Med. Exam’rs., No. 160952,
2016 WL 6900723, at *10 (C.D. Cal. Aug. 25, 2016). The court went on to emphasize that
NBME “does not have the authority to ‘control the means and manner’ of [plaintiff’s]
performance as a physician, nor does it exercise ‘substantial control’ over the terms or conditions
of her employment.” Id. Plaintiffs object that Kiprilov does not directly engage with Sibley’s
interference theory, but the reasoning in Kiprilov is nevertheless illustrative: it reveals a much
more tangential connection between NBME and an applicant’s ultimate employer than the close
nexus between the hospital and private nurse registry in Sibley. Employing the same logic,
courts have held that Title VII does not apply to bar examination boards or to the American
Board of Internal Medicine. See Woodard v. Virginia Bd. of Bar Exam’rs, 598 F.2d 1345, 1346
(4th Cir. 1979), Munsif v. Am. Bd. of Internal Med., No. 11-5949, 2012 WL 3962671, at *14
(E.D. Pa. Sept. 11, 2012)).
And contrary to Plaintiffs’ contention, this Court’s ruling in Taylor v. Pompeo, No. 192987 (CRC), 2021 WL 7904001 (D.D.C. Jan. 6, 2021), does not dictate otherwise. In that case,
an Assistant United States Attorney secured a detail at the U.S. Embassy in Afghanistan, but his
posting was rescinded after the government declined to issue him a medical clearance. Id. at *1.
Although Taylor was employed by the Department of Justice, the Court permitted his suit to
17
proceed against the Department of State, Department of Defense, and Air Force because those
entities allegedly “controlled the medical clearance process.” Id. at *4. Taylor had already
secured a specific employment position and one hiring requirement—that could have been
performed by the employer itself—had been delegated to three outside entities. Thus, DOS,
DOD, and the Air Force essentially acted in the role of Taylor’s employer with respect to the
medical-clearance process. Here, passing the USMLE represents only the first step in the
involved Match process described above, which may or may not lead to placement in a residency
program. Satisfactory performance on the exam permits an applicant to enter the Match
program, but it does not guarantee her any particular job or any job at all. The relationship
between NBME and a residency applicant is thus far afield from that between an employer and
employee. See George, 794 F.2d at 114.
Plaintiffs also rely on Ass’n of Mexican-American Educators v. State of California, 231
F.3d 572, 580–82 (9th Cir. 2000), which held that Title VII applied to a California state agency
administering a teacher certification test even though the teachers were employed by individual
school districts. Opp’n at 15–16. In reaching that conclusion, however, the Ninth Circuit
explicitly distinguished precedent holding that licensing boards are not subject to Title VII based
on California’s “high level of involvement in the operation of local public schools.” Id. at 582.
That case therefore turned on the particularities of the state’s control over its public-school
system and has little to say about cases like this one where “licensing [is] the entire connection
between the plaintiffs and the defendants.” Id.
Because NBME does not employ Plaintiffs or qualify for the Sibley exception, the Court
would dismiss their Title VII claims even if it were to reach the merits.
18
2. Section 1981 Claims
Plaintiffs’ Section 1981 claims fare no better. The outcome of those claims is controlled
by Giri I. Recall that the Board conducted a statistical analysis of (1) Step One and Two testtakers who sat for the exam in Nepal or self-identified as a citizen of Nepal, and (2) Step Three
test-takers who attended medical school in Nepal or self-identified as a citizen of Nepal. Jurich
Decl. ¶ 18. As the Court noted in its prior opinion, “[c]onspicuously lacking from these criteria
is a limitation to those of Nepali ethnicity or national origin.” Giri I, 718 F. Supp. 3d at 39–40.
And any overlap between people of Nepali citizenship and ethnicity is “insufficient to show that
the Board took action on the basis of ethnicity, as distinct from national origin, which [Plaintiffs]
must do to make out [their] § 1981 race-discrimination claim.” Id. at 40.
Plaintiffs respond that since they are “natives and citizens of Nepal,” their “national
origin and ethnicity ‘are identical as a factual matter,’” such that they have plausibly alleged
discrimination on the basis of ethnicity, as well as national origin. Opp’n at 31. But even at this
stage of the proceedings, Plaintiffs have not done enough to allege “discrimination [] based on
‘ancestry or ethnic characteristics,’ not on [their] country of origin.” Ndondji v. InterPark Inc.,
768 F. Supp. 2d 263, 273 (D.D.C. 2011) (citation omitted). Their factual allegations are entirely
“devoted to discriminatory acts based on [their] national origin,” id.; specifically, they complain
that NBME conducted additional analyses of exams completed by citizens of Nepal. Jurich
Decl. ¶ 11–13. But they offer no allegations suggesting that any of NBME’s actions were taken
“based on racial or ethnic characteristics associated with” Nepali national origin. Amiri v. Hilton
Wash. Hotel, 360 F. Supp. 2d 38, 42 (D.D.C. 2003) (citation omitted), aff’d sub nom. Amiri v.
Wash. Hilton Hotel, 173 F. App’x 1 (D.C. Cir. 2005). The complaint includes no allegations
specific to Plaintiffs’ race or ethnicity and identifies purportedly similarly situated test-takers by
19
country of origin, not by race, suggesting that Plaintiffs “perceived being [‘Nepali’] as referring
to [their] national origin and not [their] race.” Ndondji, 768 F. Supp. 2d at 273. Plaintiffs’
Section 1981 claims thus rest entirely on their Nepali national origin, but “a plaintiff cannot base
proof of discrimination under § 1981 solely on the place or nation of his origin.’” Kidane v. Nw.
Airlines, Inc., 41 F. Supp. 2d 12, 17 (D.D.C. 1999) (emphasis added).
Plaintiffs’ claims are therefore substantively identical to numerous Section 1981 claims
dismissed by courts in this district. See, e.g., Ndondji, 768 F. Supp. 2d at 273–75 (dismissing
Section 1981 claim based solely on plaintiff’s Angolan national origin); Kidane, 41 F. Supp. 2d
at 16–17 (dismissing Section 1981 claims based solely on the fact that plaintiff was from
Ethiopia); Amiri, 360 F. Supp. 2d at 42–43 (dismissing Section 1981 claim “solely based on the
fact [plaintiff] is from Afghanistan”); Kalantar v. Lufthansa Ger. Airlines, 402 F. Supp. 2d 130,
138 (D.D.C. 2005) (granting summary judgment to defendant on Section 1981 claim because
plaintiff “has not brought forward any evidence that he was singled out [] on the basis of []
‘racial or ethnic characteristics’ as opposed to his [Iranian] citizenship”). The Court likewise
concludes that Plaintiffs’ Section 1981 claims fail on the merits. Indeed, to hold otherwise
would permit plaintiffs to proceed further on a claim of “national origin discrimination per se,”
which Section 1981 does not permit. Ndondji, 768 F. Supp. 2d at 273.
20
IV. Conclusion
For these reasons, the Court will grant Defendant’s Motion to Dismiss. A separate Order
accompanies this Opinion.
CHRISTOPHER R. COOPER
United States District Judge
Date: January 27, 2025
21
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?